The Caledonian-Record

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- ...